Amwell (AMWL) stock price, revenue, and financials

Amwell market cap is $8.3 b, and annual revenue was $148.86 m in FY 2019

$8.3 B

AMWL Mkt cap, 08-Feb-2021

$62.6 M

Amwell Revenue Q3, 2020
Amwell Gross profit (Q3, 2020)20.4 M
Amwell Gross profit margin (Q3, 2020), %32.7%
Amwell Net income (Q3, 2020)-64.6 M
Amwell EBIT (Q3, 2020)-64.3 M
Amwell Cash, 30-Sept-2020956.4 M
Amwell EV7.3 B

Amwell Revenue

Amwell revenue was $148.86 m in FY, 2019 which is a 30.6% year over year increase from the previous period.

Embed Graph

Amwell Revenue Breakdown

Embed Graph

Amwell revenue breakdown by business segment: 56.2% from Platform subscription, 27.3% from Visits and 16.4% from Other

Amwell Income Statement

Annual

USDFY, 2018FY, 2019

Revenue

114.0m148.9m

Revenue growth, %

31%

Cost of goods sold

58.6m80.0m

Gross profit

55.3m68.9m

Gross profit Margin, %

49%46%

Sales and marketing expense

31.6m47.7m

R&D expense

36.3m53.9m

General and administrative expense

37.2m54.2m

Operating expense total

110.4m155.8m

Depreciation and amortization

5.3m7.8m

EBIT

(55.1m)(94.7m)

EBIT margin, %

(48%)(64%)

Pre tax profit

(52.3m)(89.2m)

Income tax expense

(803.0k)

Net Income

(52.3m)(88.4m)

EPS

(1.3)(2.1)

Amwell Balance Sheet

Annual

USDFY, 2018FY, 2019

Cash

48.0m137.7m

Accounts Receivable

30.8m32.7m

Prepaid Expenses

4.8m8.9m

Inventories

2.5m3.1m

Current Assets

300.2m223.5m

PP&E

3.1m2.7m

Goodwill

127.3m193.9m

Total Assets

489.3m499.9m

Accounts Payable

4.2m6.5m

Short-term debt

6.2m

Current Liabilities

87.8m106.6m

Long-term debt

7.2m

Total Debt

13.4m

Total Liabilities

118.0m124.9m

Common Stock

414.0k423.0k

Additional Paid-in Capital

37.1m50.3m

Retained Earnings

(270.7m)(357.9m)

Total Equity

(204.4m)(280.9m)

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

-2.4 x-1.8 x

Quarterly

USDQ3, 2020

Cash

956.4m

Accounts Receivable

40.0m

Prepaid Expenses

8.4m

Inventories

7.8m

Current Assets

1.1b

PP&E

4.4m

Goodwill

193.9m

Total Assets

1.4b

Accounts Payable

7.7m

Short-term debt

6.3m

Current Liabilities

106.6m

Long-term debt

3.1m

Total Debt

9.4m

Total Liabilities

117.3m

Common Stock

2.3m

Additional Paid-in Capital

1.8b

Retained Earnings

(532.0m)

Total Equity

1.3b

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.1 x

Amwell Cash Flow

Annual

USDFY, 2018FY, 2019

Net Income

(53.3m)(88.4m)

Depreciation and Amortization

5.3m7.8m

Accounts Receivable

(19.5m)803.0k

Inventories

1.6m(592.0k)

Accounts Payable

(787.0k)1.2m

Cash From Operating Activities

(74.0m)(81.9m)

Purchases of PP&E

(1.9m)(1.3m)

Cash From Investing Activities

(245.9m)120.0m

Cash From Financing Activities

278.2m46.6m

Net Change in Cash

(41.8m)84.7m

Income Taxes Paid

193.0k

Quarterly

USDQ3, 2019Q3, 2020

Net Income

(65.6m)(178.0m)

Depreciation and Amortization

5.7m7.4m

Accounts Receivable

11.9m(8.5m)

Inventories

(500.0k)(4.7m)

Accounts Payable

13.0k(135.0k)

Cash From Operating Activities

(66.6m)(87.9m)

Purchases of PP&E

(1.1m)(3.3m)

Cash From Investing Activities

146.5m(96.7m)

Cash From Financing Activities

452.0k1.0b

Net Change in Cash

80.3m818.7m

Income Taxes Paid

138.0k

Amwell Ratios

USDFY, 2018

Financial Leverage

-2.4 x

Amwell Operating Metrics

May, 2020Feb, 2021

Customers (Service Providers)

62 k

Health Projects

240

Hospitals Served

2 k2 k

Members

80 m

Partners

55 55

Amwell Employee Rating

3.5113 votes
Culture & Values
3.6
Work/Life Balance
3.5
Senior Management
3.5
Salary & Benefits
3.8
Career Opportunities
3.6
Source